Omnicell (OMCL) Cash & Equivalents (2010 - 2026)

Omnicell (OMCL) has 17 years of Cash & Equivalents data on file, last reported at $239.2 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 38.16% year-over-year to $239.2 million in Q1 2026; TTM through Mar 2026 was $239.2 million, a 38.16% decrease from a year earlier, with the FY2025 full-year figure at $196.5 million, down 46.78% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $239.2 million, up from $196.5 million in the prior quarter.
• Over the last five years, Cash & Equivalents for OMCL reached as high as $570.6 million in Q3 2024 and fell as low as $180.1 million in Q3 2025.
• Historically, Cash & Equivalents has averaged $360.3 million across 5 years, with a median of $352.2 million in 2025.
• Across the five-year window, Cash & Equivalents jumped 67.73% in 2023 and sank 68.45% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $330.4 million in 2022, then jumped by 41.65% to $468.0 million in 2023, then fell by 21.11% to $369.2 million in 2024, then slumped by 46.78% to $196.5 million in 2025, then increased by 21.73% to $239.2 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $239.2 million in Q1 2026, $196.5 million in Q4 2025, and $180.1 million in Q3 2025.